Skip to main content

Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (NovoSeven).

Publication ,  Journal Article
Tanaka, KA; Waly, AA; Cooper, WA; Levy, JH
Published in: Anesthesiology
June 2003

Duke Scholars

Published In

Anesthesiology

DOI

ISSN

0003-3022

Publication Date

June 2003

Volume

98

Issue

6

Start / End Page

1513 / 1515

Location

United States

Related Subject Headings

  • Recombinant Proteins
  • Postoperative Hemorrhage
  • Mitral Valve
  • Middle Aged
  • Male
  • Jehovah's Witnesses
  • Intraoperative Complications
  • Humans
  • Hemostatics
  • Hemorrhage
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Tanaka, K. A., Waly, A. A., Cooper, W. A., & Levy, J. H. (2003). Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (NovoSeven). Anesthesiology, 98(6), 1513–1515. https://doi.org/10.1097/00000542-200306000-00034
Tanaka, Kenichi A., Amr A. Waly, William A. Cooper, and Jerrold H. Levy. “Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (NovoSeven).Anesthesiology 98, no. 6 (June 2003): 1513–15. https://doi.org/10.1097/00000542-200306000-00034.
Tanaka, Kenichi A., et al. “Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (NovoSeven).Anesthesiology, vol. 98, no. 6, June 2003, pp. 1513–15. Pubmed, doi:10.1097/00000542-200306000-00034.
Tanaka KA, Waly AA, Cooper WA, Levy JH. Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (NovoSeven). Anesthesiology. 2003 Jun;98(6):1513–1515.

Published In

Anesthesiology

DOI

ISSN

0003-3022

Publication Date

June 2003

Volume

98

Issue

6

Start / End Page

1513 / 1515

Location

United States

Related Subject Headings

  • Recombinant Proteins
  • Postoperative Hemorrhage
  • Mitral Valve
  • Middle Aged
  • Male
  • Jehovah's Witnesses
  • Intraoperative Complications
  • Humans
  • Hemostatics
  • Hemorrhage